Publication: New Promising Results from the Dutch CAR-T Tumorboard Experience.
Chimeric antigen receptor T-cell therapy, also known as CAR T-cell therapy, is a form of immunotherapy utilised in the treatment of cancer. For this therapy, a technique involves altering T […]
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 875171.